MX9604367A - Hidroxipiridinonas novedosas. - Google Patents
Hidroxipiridinonas novedosas.Info
- Publication number
- MX9604367A MX9604367A MX9604367A MX9604367A MX9604367A MX 9604367 A MX9604367 A MX 9604367A MX 9604367 A MX9604367 A MX 9604367A MX 9604367 A MX9604367 A MX 9604367A MX 9604367 A MX9604367 A MX 9604367A
- Authority
- MX
- Mexico
- Prior art keywords
- hydroxypyridinones
- novel
- iron
- hydroxypyridin
- warm
- Prior art date
Links
- GGOZGYRTNQBSSA-UHFFFAOYSA-N pyridine-2,3-diol Chemical class OC1=CC=CN=C1O GGOZGYRTNQBSSA-UHFFFAOYSA-N 0.000 title 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- LQUSVSANJKHVTM-UHFFFAOYSA-N 3-hydroxy-3h-pyridin-4-one Chemical class OC1C=NC=CC1=O LQUSVSANJKHVTM-UHFFFAOYSA-N 0.000 abstract 1
- 206010022979 Iron excess Diseases 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH275995 | 1995-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9604367A true MX9604367A (es) | 1997-10-31 |
Family
ID=4240981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9604367A MX9604367A (es) | 1995-09-29 | 1996-09-26 | Hidroxipiridinonas novedosas. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5688815A (de) |
| EP (1) | EP0768302B1 (de) |
| JP (1) | JPH09124603A (de) |
| KR (1) | KR970015576A (de) |
| CN (1) | CN1151399A (de) |
| AR (1) | AR005419A1 (de) |
| AT (1) | ATE299135T1 (de) |
| AU (1) | AU6584596A (de) |
| BR (1) | BR9603929A (de) |
| CA (1) | CA2186716A1 (de) |
| CZ (1) | CZ284896A3 (de) |
| DE (1) | DE59611243D1 (de) |
| ES (1) | ES2244967T3 (de) |
| HU (1) | HUP9602681A1 (de) |
| IL (1) | IL119316A (de) |
| MX (1) | MX9604367A (de) |
| NO (1) | NO964095L (de) |
| NZ (1) | NZ299452A (de) |
| PT (1) | PT768302E (de) |
| SA (1) | SA96170399B1 (de) |
| TR (1) | TR199600765A2 (de) |
| ZA (1) | ZA968150B (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6448273B1 (en) | 1997-05-29 | 2002-09-10 | Btg International Limited | Orally active iron (III) chelators |
| GB9711093D0 (en) | 1997-05-29 | 1997-07-23 | British Tech Group | Novel orally active iron (III) chelators |
| GB9723078D0 (en) * | 1997-10-31 | 1998-01-07 | Cerebrus Ltd | Chemical compounds |
| JPH11147377A (ja) * | 1997-11-18 | 1999-06-02 | Teijin Ltd | 感熱転写リボン用二軸配向ポリエステルフィルム |
| JP4972261B2 (ja) * | 1999-08-27 | 2012-07-11 | ライフ テクノロジーズ コーポレーション | 金属結合化合物および細胞培養培地組成物中でのそれらの使用 |
| US6767741B1 (en) | 1999-08-27 | 2004-07-27 | Invitrogen Corporation | Metal binding compounds and their use in cell culture medium compositions |
| US6846915B2 (en) | 2001-08-13 | 2005-01-25 | The Regents Of The University Of California | Hydroxypyridonate and hydroxypyrimidinone chelating agents |
| US6426418B1 (en) | 2001-11-02 | 2002-07-30 | Apotex, Inc. | Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
| JP2005516987A (ja) | 2002-02-05 | 2005-06-09 | ブリストル−マイヤーズ スクイブ カンパニー | Ｎ−置換された３−ヒドロキシ−４−ピリジノン化合物およびそれを含む医薬 |
| US20050008699A1 (en) * | 2003-07-11 | 2005-01-13 | Fred Wehling | Effervescent glucosamine composition |
| NZ529657A (en) * | 2003-11-20 | 2004-07-30 | Apotex Inc | Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
| CA2488034C (en) * | 2004-11-19 | 2009-10-06 | Apotex Inc. | Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues |
| GB0506677D0 (en) * | 2005-04-01 | 2005-05-11 | Btg Int Ltd | Iron modulators |
| CN103951643B (zh) | 2008-07-25 | 2015-12-09 | 盐野义制药株式会社 | 用作hiv整合酶抑制剂的化合物 |
| EP2334188A4 (de) * | 2008-08-15 | 2012-08-08 | Burnham Inst Medical Research | Zusammensetzung und verfahren für den entwurf und die entwicklung von metalloenzymhemmern |
| KR101678563B1 (ko) * | 2008-12-11 | 2016-11-22 | 비이브 헬쓰케어 컴퍼니 | 카르바모일피리돈 ｈｉｖ 인테그라제 억제제를 위한 제조방법 및 중간체 |
| KR101733625B1 (ko) | 2008-12-11 | 2017-05-10 | 시오노기세야쿠 가부시키가이샤 | 카르바모일피리돈 ｈｉｖ 인테그라제 억제제 및 중간체의 합성 |
| TWI518084B (zh) | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
| CN101906069B (zh) * | 2009-06-02 | 2012-12-12 | 首都医科大学 | (s)-2-取代-(3＇-乙酰基-2＇-吡啶酮-1＇-基)乙酸及其制备方法和应用 |
| ME01911B (me) * | 2009-07-03 | 2014-12-20 | Apotex Tech Inc | Fluorisani derivati 3-hidroksipiridin-4-ona |
| TWI582097B (zh) | 2010-03-23 | 2017-05-11 | Ｖｉｉｖ醫療保健公司 | 製備胺甲醯吡啶酮衍生物及中間體之方法 |
| BR112013001953A2 (pt) * | 2010-07-27 | 2018-05-15 | Clariant Finance Bvi Ltd | uso de hidroxipiridonas ou sais dos mesmos para a estabilização de peróxido de hidrogênio ou substâncias doadoras de peróxido de hidrogênio |
| CN105017138A (zh) * | 2015-08-06 | 2015-11-04 | 中国科学技术大学 | 一种乙二醇化3-羟基吡啶-4-酮类化合物及其制备方法和用途 |
| CN110790737B (zh) * | 2019-11-07 | 2022-07-22 | 河南中烟工业有限责任公司 | 一种2,3-二氢-3,5-二羟基-6-乙基-4h-吡喃-4-酮的制备方法 |
| CN118496186B (zh) * | 2024-05-14 | 2025-09-02 | 海南师范大学 | 一种吡喃酮衍生物及其制备方法与应用 |
| CN119977990B (zh) * | 2024-12-30 | 2026-03-31 | 海南师范大学 | 一种海洋真菌来源的杀虫杀菌化合物及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1518098A1 (de) * | 1963-09-19 | 1969-04-10 | Pfizer & Co C | Verfahren zur Herstellung von Pyromekonsaeurederivaten |
| GB2118176B (en) * | 1982-03-24 | 1985-12-04 | Nat Res Dev | Pharmaceutical compositions |
| GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| US4908371A (en) * | 1987-11-10 | 1990-03-13 | Ciba-Geigy Corporation | Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload |
| EP0325559B1 (de) * | 1988-01-20 | 1993-12-15 | Ciba-Geigy Ag | Verfahren zur Herstellung von Komplexverbindungen |
| EP0335745A1 (de) * | 1988-03-31 | 1989-10-04 | The Royal Free Hospital School Of Medicine | Verfahren zur Herstellung von Pyridin-4-onen |
| US4980371A (en) * | 1988-12-21 | 1990-12-25 | Merrell Dow Pharmaceuticals | Antiretroviral furan ketones |
| US5112968A (en) * | 1989-07-28 | 1992-05-12 | E. R. Squibb & Sons, Inc. | Monobactam hydrazide derivatives |
| GB9100465D0 (en) * | 1991-01-09 | 1991-02-20 | Hider Robert C | Pharmaceutical compositions |
| GB9209078D0 (en) * | 1992-04-27 | 1992-06-10 | Hider Robert C | Pharmaceutical compositions |
| CA2100623A1 (en) * | 1992-07-17 | 1994-01-18 | Michiyuki Sendai | Cephem compounds, their production and use |
| GB9216506D0 (en) * | 1992-08-04 | 1992-09-16 | Rice Evans Catherine A | Improvements in or relating to the treatment of sickle cell disease |
| GB9217099D0 (en) * | 1992-08-12 | 1992-09-23 | British Tech Group | Pharmaceutical compositions |
| US5789426A (en) * | 1995-01-20 | 1998-08-04 | Cornell Research Foundation, Inc. | Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
-
1996
- 1996-09-20 ES ES96810622T patent/ES2244967T3/es not_active Expired - Lifetime
- 1996-09-20 AT AT96810622T patent/ATE299135T1/de active
- 1996-09-20 DE DE59611243T patent/DE59611243D1/de not_active Expired - Lifetime
- 1996-09-20 PT PT96810622T patent/PT768302E/pt unknown
- 1996-09-20 EP EP96810622A patent/EP0768302B1/de not_active Expired - Lifetime
- 1996-09-25 AU AU65845/96A patent/AU6584596A/en not_active Abandoned
- 1996-09-25 KR KR1019960042392A patent/KR970015576A/ko not_active Withdrawn
- 1996-09-26 TR TR96/00765A patent/TR199600765A2/xx unknown
- 1996-09-26 AR ARP960104510A patent/AR005419A1/es unknown
- 1996-09-26 MX MX9604367A patent/MX9604367A/es unknown
- 1996-09-26 NZ NZ299452A patent/NZ299452A/en unknown
- 1996-09-27 BR BR9603929A patent/BR9603929A/pt not_active Application Discontinuation
- 1996-09-27 ZA ZA968150A patent/ZA968150B/xx unknown
- 1996-09-27 NO NO964095A patent/NO964095L/no unknown
- 1996-09-27 CA CA002186716A patent/CA2186716A1/en not_active Abandoned
- 1996-09-27 US US08/722,820 patent/US5688815A/en not_active Expired - Lifetime
- 1996-09-27 IL IL11931696A patent/IL119316A/xx not_active IP Right Cessation
- 1996-09-27 HU HU9602681A patent/HUP9602681A1/hu unknown
- 1996-09-27 CN CN96121129A patent/CN1151399A/zh active Pending
- 1996-09-27 CZ CZ962848A patent/CZ284896A3/cs unknown
- 1996-09-30 JP JP8259294A patent/JPH09124603A/ja active Pending
- 1996-10-30 SA SA96170399A patent/SA96170399B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6584596A (en) | 1997-04-10 |
| SA96170399B1 (ar) | 2007-01-20 |
| EP0768302B1 (de) | 2005-07-06 |
| EP0768302A3 (de) | 1998-02-25 |
| JPH09124603A (ja) | 1997-05-13 |
| NO964095L (no) | 1997-04-01 |
| HU9602681D0 (en) | 1996-11-28 |
| NZ299452A (en) | 1998-06-26 |
| US5688815A (en) | 1997-11-18 |
| ES2244967T3 (es) | 2005-12-16 |
| IL119316A0 (en) | 1996-12-05 |
| CN1151399A (zh) | 1997-06-11 |
| DE59611243D1 (de) | 2005-08-11 |
| CZ284896A3 (en) | 1997-04-16 |
| KR970015576A (ko) | 1997-04-28 |
| AR005419A1 (es) | 1999-06-23 |
| ATE299135T1 (de) | 2005-07-15 |
| IL119316A (en) | 2000-08-13 |
| ZA968150B (en) | 1997-04-01 |
| BR9603929A (pt) | 1998-06-09 |
| PT768302E (pt) | 2005-11-30 |
| HUP9602681A1 (en) | 1997-09-29 |
| TR199600765A2 (tr) | 1997-05-21 |
| CA2186716A1 (en) | 1997-03-30 |
| NO964095D0 (no) | 1996-09-27 |
| EP0768302A2 (de) | 1997-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG103485A (en) | Ketobanzamides as calpain inhibitors | |
| GR3023233T3 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
| TW289757B (de) | ||
| BG105784A (en) | Triazole compounds with dopamine-d3-receptor affinity | |
| ZA200109995B (en) | Nematicidal Trifluorobutenes. | |
| MY138966A (en) | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses | |
| SG47520A1 (en) | New method for the production of 9-amino-6-demethyl-6-deoxytetracycline | |
| BG105270A (en) | Tetrahydropyridoethers | |
| GR3030342T3 (en) | Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase. | |
| NZ311403A (en) | Imidazole compounds and pharmaceuticals | |
| CA2109613A1 (en) | Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles | |
| MX9709240A (es) | Fenilpiridazinonas. | |
| GB9308957D0 (en) | Novel produgs | |
| IN2012DE00109A (de) | ||
| BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
| MY107819A (en) | Preparation of substituted piperidines. | |
| NO964095L (no) | Nye hydroksypyridinoner | |
| IL117209A (en) | 1-aryl-2-acylamino-ethane compounds and pharmaceutical compositions containing them | |
| MY125674A (en) | Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis | |
| BG106002A (en) | Process for preparing pesticidal intermediates | |
| IN187760B (de) | ||
| BG104292A (en) | Methods and compositions for the treatment of rheumatoid arthritis | |
| ID27440A (id) | Proses untuk menyiapkan penengah-penengah | |
| GB9920959D0 (en) | Novel process | |
| ZA983231B (en) | Substituted benzyloxyimino compounds. |